Krystal Biotech, Inc.

Krystal Biotech, Inc.verified

KRYS

Price:

$157.91

Market Cap:

$4.54B

Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing KB105 that is in Phase I/II clinical study for treating patients with deficient autosomal recessive congenital ichthyosis; KB301, which is in Phase I/II clinical stage for treating wrinkles and other presentations of aged or damaged skin; KB407 that is in preclinical stage for cystic fibrosis; and KB104, which is in preclinical stage for netherton syn...[Read more]

Industry

Biotechnology

IPO Date

2017-09-20

Stock Exchange

NASDAQ

Ticker

KRYS

The ROE as of December 2024 (TTM) for Krystal Biotech, Inc. (KRYS) is 6.34%

According to Krystal Biotech, Inc.’s latest financial reports and current stock price. The company's current ROE is 6.34%. This represents a change of 312.09% compared to the average of 1.54% of the last 4 quarters.

Krystal Biotech, Inc. (KRYS) Historical ROE (quarterly & annually)

How has KRYS ROE performed in the past?

The mean historical ROE of Krystal Biotech, Inc. over the last ten years is -60.14%. The current 6.34% ROE has changed -110.55% with respect to the historical average. Over the past ten years (40 quarters), KRYS's ROE was at its highest in in the September 2023 quarter at 10.68%. The ROE was at its lowest in in the December 2016 quarter at -216.96%.

Quarterly (TTM)
Annual

Average

-60.14%

Median

-11.37%

Minimum

-397.92%

Maximum

1.40%

Krystal Biotech, Inc. (KRYS) ROE by Quarter and Year

Discovering the peaks and valleys of Krystal Biotech, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 128.69%

Maximum Annual ROE = 1.40%

Minimum Annual Increase = -105.24%

Minimum Annual ROE = -397.92%

Quarterly (TTM)
Annual
YearROEChange
20231.40%-105.24%
2022-26.80%128.69%
2021-11.72%6.42%
2020-11.01%17.07%
2019-9.41%-2.18%
2018-9.62%-39.93%
2017-16.01%-95.98%

Krystal Biotech, Inc. (KRYS) Average ROE

How has KRYS ROE performed in the past?

The current ROE of Krystal Biotech, Inc. (KRYS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-12.37%

5-year avg

-11.51%

10-year avg

-60.14%

Krystal Biotech, Inc. (KRYS) ROE vs. Peers

How is KRYS’s ROE compared to its peers?

Krystal Biotech, Inc.’s ROE is greater than MeiraGTx Holdings plc (-80.95%), greater than Apellis Pharmaceuticals, Inc. (-103.92%), greater than Deciphera Pharmaceuticals, Inc. (-52.42%), greater than REGENXBIO Inc. (-70.65%), greater than Rhythm Pharmaceuticals, Inc. (-369.26%),

Build a custom stock screener for Krystal Biotech, Inc. (KRYS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Krystal Biotech, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Krystal Biotech, Inc. (KRYS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Krystal Biotech, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Krystal Biotech, Inc.'s ROE?

How is the ROE calculated for Krystal Biotech, Inc. (KRYS)?

What is the highest ROE for Krystal Biotech, Inc. (KRYS)?

What is the 3-year average ROE for Krystal Biotech, Inc. (KRYS)?

What is the 5-year average ROE for Krystal Biotech, Inc. (KRYS)?

How does the current ROE for Krystal Biotech, Inc. (KRYS) compare to its historical average?